BIO From The Editor and Guest Columns
-
Navigating Tariffs: Implications And Strategies For Pharmaceuticals Manufacturers
4/17/2025
The U.S. tariffs on trading partners bring a whole new set of challenges, but there are tactics and strategies companies can deploy to help offset the cost and operational impacts.
-
Why You Need A Raw Material Control Strategy
4/17/2025
You should start with the end goal in mind, but the first draft is almost never the last. These living documents should evolve as your team gains process knowledge.
-
Why Pharma Risk Assessments Should Include 'Working Together Alone'
4/16/2025
When understood and managed properly, subjectivity becomes a source of creativity. It reveals hidden hazards and unlocks more effective risk controls.
-
Climbing The Blockchain Ladder To Optimize Clinical Supply Forecasting
4/16/2025
Layering AI on top of blockchain technology offers a powerful way to predict kinks in the supply chain. Here's a look at where the technology is headed.
-
How CAR-NKs Offer Powerful Therapeutic Flexibility
4/15/2025
Induced pluripotent stem cells have emerged as a promising platform for producing CAR-engineered NK cells in a standardized, renewable, and scalable way.
-
Ramping Up GMP-Compliant CAR-NK Manufacturing At Scale With iPSCs
4/15/2025
The ability to produce billions of NK cells in a single production run represents a transformative shift in the economics and logistics of cell therapy.
-
Pharmaceutical Sovereignty: The Resilience We Cannot Outsource
4/15/2025
Pharmaceutical sovereignty is no longer a theoretical concern. Sovereignty in this context does not imply isolation, but rather strategic resilience: building robust national and regional capabilities that ensure security while enabling global collaboration.
-
From BPI West: A Roundtable Discussion On Continuous Manufacturing
4/14/2025
Process Development experts share their thoughts on continuous manufacturing at this year's BPI West, touching on its benefits and present barriers to adoption.
-
How AI Is A Game-Changer For Auditing Compliance And Efficiency
4/9/2025
In the life sciences, audits have long been bogged down by repetitive tasks. AI is changing the way auditors operate, making compliance more seamless than ever.
-
March 2025 — CDMO Opportunities And Threats Report
4/8/2025
Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections.